BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 27038446)

  • 1. Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.
    Ghaus S; Neumann H; Muhammad H; Tontini GE; Ishaq S
    Dig Dis Sci; 2016 Aug; 61(8):2185-2193. PubMed ID: 27038446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Barrett's esophagus: diagnosis and therapy].
    Schmassmann A; Gebbers JO
    Praxis (Bern 1994); 2005 May; 94(21):861-8. PubMed ID: 15966485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses.
    Corley DA; Kubo A; DeBoer J; Rumore GJ
    Gastrointest Endosc; 2009 May; 69(6):1004-10. PubMed ID: 19152897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus: histopathologic definitions and diagnostic criteria.
    Mueller J; Werner M; Stolte M
    World J Surg; 2004 Feb; 28(2):148-54. PubMed ID: 14727064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].
    Peitz U; Malfertheiner P
    Z Gastroenterol; 2007 Dec; 45(12):1264-72. PubMed ID: 18080229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.
    Sharma P; Katzka DA; Gupta N; Ajani J; Buttar N; Chak A; Corley D; El-Serag H; Falk GW; Fitzgerald R; Goldblum J; Gress F; Ilson DH; Inadomi JM; Kuipers EJ; Lynch JP; McKeon F; Metz D; Pasricha PJ; Pech O; Peek R; Peters JH; Repici A; Seewald S; Shaheen NJ; Souza RF; Spechler SJ; Vennalaganti P; Wang K
    Gastroenterology; 2015 Nov; 149(6):1599-606. PubMed ID: 26296479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's esophagus surveillance: When, how often, does it work?
    Katona BW; Falk GW
    Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):9-24. PubMed ID: 21112494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best Practices in Surveillance for Barrett's Esophagus.
    Triggs JR; Falk GW
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):59-75. PubMed ID: 33213800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surveillance of patients with Barrett's esophagus].
    Endlicher E; Knüchel R; Messmann H
    Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
    Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP
    Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma.
    Hillman LC; Chiragakis L; Clarke AC; Kaushik SP; Kaye GL
    J Gastroenterol Hepatol; 2003 May; 18(5):526-33. PubMed ID: 12702044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Barrett's esophagus: screening and prognosis].
    Mazzucchelli L; Wagner AC
    Ther Umsch; 2001 Mar; 58(3):158-64. PubMed ID: 11305154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Endoluminal Technologies for Barrett's Esophagus: Focus on Optical Coherence Tomography and Confocal Laser Endomicroscopy.
    Zihni AM; DeMeester SR
    Thorac Surg Clin; 2018 Nov; 28(4):465-472. PubMed ID: 30268292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.